Relationship Between Progression-Free Survival and Overall Survival Benefit: A Simulation Study

被引:11
|
作者
Zhang, Lijun [1 ]
Ko, Chia-Wen [1 ]
Tang, Shenghui [1 ]
Sridhara, Rajeshwari [1 ]
机构
[1] US FDA, Ctr Drug Evaluat & Res, Div Biometr 5, Off Biostat,Off Translat Sci, Silver Spring, MD USA
关键词
clinical trial; overall survival; progression-free survival; crossover; survival post progression; END-POINTS;
D O I
10.1177/0092861512459180
中图分类号
R-058 [];
学科分类号
摘要
This study evaluated the circumstances under which the observed progression-free survival (PFS) benefit may translate into an overall survival (OS) benefit. Methods: A simulation study, based on PFS and OS joint model decomposition, was conducted to evaluate the impact of crossover rates, survival post progression (SPP) lengths, and magnitudes of difference in median PFS on OS. Under different simulation scenarios, the degree of impact was investigated based on the probability of observing a significant OS benefit given an observed PFS benefit. Results: Using simulation parameters defined based on historical NDA datasets, the probability of detecting an OS benefit given the observed PFS benefit depends largely on crossover rate and SPP length (ie, SPP median times). Compared to no crossover, a crossover rate of <= 50% decreases the probability of detecting an OS benefit by at most 15% regardless of the SPP length. A crossover rate of > 50% decreases the probability of detecting an OS benefit much further, and the extent of decrease is proportional to the length of SPP. Conclusion: Crossover rate and SPP length are important factors affecting the benefit translating from PFS to OS. This simulation study identified a threshold, of 50%, for crossover rate that is likely to confound OS effect. With a greater than 50% crossover rate, longer SPP further decreases the probability of translating a PFS benefit to OS.
引用
收藏
页码:95 / 100
页数:6
相关论文
共 50 条
  • [1] Relationship Between Progression-Free Survival and Overall Survival Benefit: A Simulation Study
    Lijun Zhang
    Chia-Wen Ko
    Shenghui Tang
    Rajeshwari Sridhara
    [J]. Therapeutic Innovation & Regulatory Science, 2013, 47 : 95 - 100
  • [2] RELATIONSHIP BETWEEN PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL IN CHRONIC LYMPHOCYTIC LEUKEMIA
    Beauchemin, C.
    Johnston, J.
    Lapierre, M. E.
    Aissa, F.
    Lachaine, J.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A414 - A415
  • [3] RELATIONSHIP BETWEEN PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL IN CHRONIC LYMPHOCYTIC LEUKEMIA
    Beauchemin, C.
    Johnston, J. B.
    Lapierre, M.
    Aissa, F.
    Lachaine, J.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 350 - 350
  • [4] Detecting an Overall Survival Benefit that Is Derived From Progression-Free Survival
    Broglio, Kristine R.
    Berry, Donald A.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (23) : 1642 - 1649
  • [5] THE ASSOCIATION BETWEEN PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL IN ONCOLOGY TRIALS: A SIMULATION EXERCISE
    Wu, D. B. C.
    Manjula, I. S.
    Yu, D.
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S198 - S198
  • [6] Relationship between overall survival and progression-free survival for recent NCCTG glioblastoma multiforme trials
    Wu, Wenting
    Galanis, Evanthia
    Buckner, Jan C.
    Jaeckle, Kurt A.
    Sargent, Daniel J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] Modeling the Relationship between Progression-Free Survival and Overall Survival: The Phase II/III Trial
    Redman, Mary W.
    Goldman, Bryan H.
    LeBlanc, Michael
    Schott, Anne
    Baker, Laurence H.
    [J]. CLINICAL CANCER RESEARCH, 2013, 19 (10) : 2646 - 2656
  • [8] The Waning Relationship Between Progression-Free Survival and Overall Survival in Randomized Cancer Therapy Trials
    Markman, Maurie
    [J]. AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2014, 10 (06) : 30 - 32
  • [9] A statistical model for the dependence between progression-free survival and overall survival
    Fleischer, Frank
    Gaschler-Markefski, Birgit
    Bluhmki, Erich
    [J]. STATISTICS IN MEDICINE, 2009, 28 (21) : 2669 - 2686
  • [10] Detecting Overall Survival Benefit Derived From Survival Postprogression Rather Than Progression-Free Survival
    Morita, Satoshi
    Sakamaki, Kentaro
    Yin, Guosheng
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (08)